Envision Healthcare (NYSE:EVHC) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.

Other research analysts have also issued research reports about the company. Robert W. Baird reaffirmed a “buy” rating and set a $70.00 price objective on shares of Envision Healthcare in a research report on Tuesday, October 17th. SunTrust Banks set a $55.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research report on Sunday, October 15th. Bank of America reduced their price objective on Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, October 9th. KeyCorp set a $67.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research report on Wednesday, November 1st. Finally, Jefferies Group set a $71.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research report on Wednesday, November 1st. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $41.50.

Envision Healthcare (EVHC) opened at $35.00 on Friday. Envision Healthcare has a 52-week low of $23.77 and a 52-week high of $73.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. The firm has a market capitalization of $4,231.12, a P/E ratio of -7.00, a P/E/G ratio of 0.91 and a beta of 0.58.

A number of institutional investors and hedge funds have recently modified their holdings of EVHC. CIBC World Markets Inc. purchased a new stake in Envision Healthcare during the 4th quarter valued at $208,000. Palisade Capital Management LLC NJ purchased a new stake in Envision Healthcare during the 3rd quarter valued at $229,000. CENTRAL TRUST Co boosted its stake in Envision Healthcare by 79.7% during the 4th quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock valued at $229,000 after purchasing an additional 2,939 shares during the last quarter. Parametrica Management Ltd purchased a new stake in Envision Healthcare during the 4th quarter valued at $236,000. Finally, Flinton Capital Management LLC boosted its stake in Envision Healthcare by 18.7% during the 2nd quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock valued at $280,000 after purchasing an additional 704 shares during the last quarter.

TRADEMARK VIOLATION WARNING: This story was reported by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.watchlistnews.com/envision-healthcare-evhc-stock-rating-lowered-by-valuengine/1844030.html.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.